LLC AG Aspect (Scientific consultant)
LLC «RDE «Astrapharm» (Scientific consultant)
Russian Federation
«Center of the veterinary aid» (Main veterinarian)
FSBEIo HE «Nizhny Novgorod State Agrotechnological University named after L.Ya. Florentiev» (NNSAU) (Department of anatomy, surgery and internal diseases, Associate Professor)
employee
Russian Federation
LLC «AG «Aspect» (Veterinarian)
LLC «RDE «Astrapharm» (Leading veterinarian)
LLC «BioFeron» (Leading veterinarian)
employee
Russian Federation
employee
Russian Federation
LLC «RDE «Astrapharm» (Chief science specialist)
LLC «BioFeron» (Chief science specialist)
employee
Russian Federation
CSCSTI 68.41
The present study provides compelling evidence that the use of the drug Trazapentine® for 14 days in the perioperative period in dogs with soft tissue neoplasms is a highly effective and safe strategy for significantly improving quality of life. An excellent safety profile, confirmed by the absence of adverse reactions, withdrawal syndrome, and systemic changes, makes this approach highly applicable for integration into standard protocols for the management of surgical patients with soft tissue neoplasms.
dogs, soft tissue neoplasms, trazodone succinate, gabapentin, Trazapentine®, efficacy, safety, quality of life
1. Beloglazov, D.V. Klinicheskaya ocenka kombinacii sukcinata trazodona i gabapentina (Trazapentin® tabletki) dlya uluchsheniya kachestva zhizni sobak pri osteoartrite/ D.V. Beloglazov, E.A. Elizarova, S.V. Mukaseev, S.A. Parhomenko, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. ‒ 2025. ‒ № 3 ‒ S. 33-42.
2. Beloglazov, D.V. Ocenka effektivnosti novogo preparata «Ekspress Uspokoin® tabletki» pri situacionnoy korrekcii povedencheskih problem u sobak / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Sovremennaya veterinarnaya medicina. – 2023. – № 1. – S. 18-22.
3. Beloglazov, D.V. Perenosimost' novogo lekarstvennogo preparata Kurs Uspokoin tabletki sobakami v usloviyah hronicheskogo opyta / D.V. Beloglazov, O.A. Zeynalov, S.V. Mukaseev // Rossiyskiy veterinarnyy zhurnal. – 2023. – № 4. – S. 31-35.
4. Beloglazov, D.V. Terapevticheskiy potencial i bezopasnost' kombinacii gabapentina i sukcinata trazodona (Trazapentin® tabletki) dlya kontrolya idiopaticheskogo cistita koshek: ot ostryh epizodov k dolgosrochnoy profilaktike / D.V. Beloglazov, E.A. Elizarova, S.V. Mukaseev, S.A. Parhomenko, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. ‒ 2025. ‒ № 2. ‒ S. 45-54.
5. Beloglazov, D.V. Trazodona sukcinat - novye vozmozhnosti farmakologicheskoy korrekcii situacionnyh povedencheskih otkloneniy u sobak i koshek / D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2021. – № 4. – S. 5-13.
6. Dobson, Dzh., Onkologiya sobak i koshek / Dzh. Dobson, D. Lascelles. ‒ M.: Akvarium-Print, 2017. ‒ 364 s.
7. Elizarova, E.A. Ocenka effektivnosti novogo lekarstvennogo preparata Kurs Uspokoin tabletki dlya korrekcii vozrastnyh kognitivnyh narusheniy u sobak / E.A. Elizarova, D.V. Beloglazov, S.V. Mukaseev, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. – 2024. – № 1. – S. 33-39.
8. Kuz'minova, E.V. Farmakologicheskaya harakteristika i toksikologicheskie parametry novogo original'nogo preparata dlya sobak Trazapentin® tabletki (sukcinat trazodona+gabapentin) / E.V. Kuz'minova, D.V. Beloglazov, S.V. Mukaseev, S.A. Parhomenko, O.A. Zeynalov // Rossiyskiy veterinarnyy zhurnal. ‒ 2025. ‒ № 3. ‒ S. 21–32.
9. Aghighi, S.A. Assessment of the effects of adjunctive gabapentin on postoperative pain after intervertebral disc surgery in dogs / S.A. Aghighi, A. Tipold, M. Piechotta, P. Lewczuk, S.V. Kästner // Vet Anaesth Analg. – 2012. ‒ No. 39(6). – pp.636-646.
10. Bianchi M.L. Quality of life assessment in cancer patients receiving single-agent versus multidrug chemotherapy protocols / M.L. Bianchi, D. Drudi \, E. Treggiari // Open Vet J. ‒ 2021. ‒ No. 11(4). – pp.755-763.
11. Bragg, R.F. Evaluation of the effects of hospital visit stress on physiologic variables in dogs / R.F. Bragg, J.S. Bennett, A. Cummings, J.M. Quimby // J Am Vet Med Assoc. – 2015. ‒ No. 246(2). – pp. 212-215.
12. Cesare F. Di. Gabapentin: Clinical Use and Pharmacokinetics in Dogs, Cats, and Horses / F. Di Cesare, V. Negro, G. Ravasio, R. Villa // Animals. ‒ 2023. ‒ No. 13(12). ‒ pp. 2045.
13. Cheng, J.K. Mechanisms of the antinociceptive action of gabapentin /J.K. Cheng, L.C. Chiou // J Pharmacol Sci. ‒ 2006. ‒ No. 100(5). ‒ pp. 471-486.
14. Crociolli, G.C. Gabapentin as an adjuvant for postoperative pain management in dogs undergoing mastectomy / G.C. Crociolli, R.N. Cassu, R.C. Barbero, T.L. Rocha, D.R. Gomes, G.M. Nicácio // J Vet Med Sci. – 2015 – No. 77(8). ‒ pp. 1011-1015.
15. Davis, L.V. Retrospective Study of 240 Dogs Receiving Gabapentin for Chronic Pain Relief / L.V. Devis // J. Vet. Med. – 2020. ‒ No. 7. ‒ pp. 1194.
16. de Nardi, A.B. Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors / A.B. de Nardi, R. Dos Santos Horta, C.E. Fonseca-Alves // Cells. – 2022. ‒ No. 11(4). – pp. 618.
17. Dhein, E.S. Incidence rates of the most common canine tumors based on data from the Swiss Canine Cancer Registry (2008 to 2020) / E.S. Dhein, U. Heikkilä, A. Oevermann // PLoS One. – 2024. ‒ No. 19(4). ‒ e0302231.
18. Di Cesare F. Gabapentin: Clinical Use and Pharmacokinetics in Dogs, Cats, and Horses / F. Di Cesare, V. Negro, G. Ravasio, R. Villa, S. Draghi, P. Cagnardi // Animals (Basel). ‒ 2023. – No. 13(12). – pp. 2045.
19. Edmunds, G. Associations Between Dog Breed and Clinical Features of Mammary Epithelial Neoplasia in Bitches: an Epidemiological Study of Submissions to a Single Diagnostic Pathology Centre Between 2008-2021 / G. Edmunds, S. Beck, K.U. Kale // J Mammary Gland Biol Neoplasia. – 2023. ‒ No. 28(1). ‒ pp. 6.
20. Edwards, P.T. Investigating risk factors that predict a dog's fear during veterinary consultations / P.T. Edwards, S.J. Hazel, M. Browne, J.A. Serpell, M.L. McArthur, B.P. Smith // PLoS One. – 2019. ‒ No. 14(7): e0215416.
21. Edwards, P.T. Implementing stress-reducing veterinary care: Perceptions of Australian veterinary professionals working with dogs / P.T. Edwards, B.P. Smith, M.L McArthur, S. Hazel // Anthrozoös. ‒ 2023 May. ‒ No. 36(519). – pp. 1-24.
22. Erickson, A. A review of pre-appointment medications to reduce fear and anxiety in dogs and cats at veterinary visits / A. Erickson, K. Harbin, J. MacPherson, K. Rundle, K.L. Overall // Can Vet J. – 2021. ‒ No. 62(9) – pp. 952-960.
23. Fan, T.M. Pain management in veterinary patients with cancer /T.M. Fan // Vet Clin North Am Small Anim Pract. – 2014. ‒ No. 44(5). – pp. 989-1001.
24. Faustino, L. Quality of life and pain in dogs with early-stage mammary tumours / L. Faustino, M. Lallo // Acta Vet Hung. – 2015. ‒ No. 63(4) – pp.451-457.
25. Fulmer, A.E. Quality of Life Measurement in Dogs and Cats: A Scoping Review of Generic Tools / A.E. Fulmer, L.J. Laven, K.E. Hill // Animals (Basel). – 2022. ‒ No. 12(3) – pp. 400.
26. Garrone, B. Synergistic interaction between trazodone and gabapentin in rodent models of neuropathic pain / B. Garrone, A. di Matteo, A. Amato // PLoS One. – 2021. ‒ 16(1). ‒ e0244649
27. Giuffrida, M.A. Development and psychometric testing of the Canine Owner-Reported Quality of Life questionnaire, an instrument designed to measure quality of life in dogs with cancer/ M.A. Giuffrida, D.S. Brown, S.S. Ellenberg, J.T. Farrar // J Am Vet Med Assoc. – 2018. ‒ No. 252(9) – pp.1073-1083.
28. Giuffrida, M.A. Quality of life measurement in prospective studies of cancer treatments in dogs and cats / M.A. Giuffrida, S.M. Kerrigan // J Vet Intern Med. – 2014. ‒ No. 28(6) – pp.
29. Gruen, M.E. AAHA Pain Management Guidelines for Dogs and Cats / M.E. Gruen, B.D.X. Lascelles, E.J. Colleran // Am Anim Hosp Assoc. ‒ 2022. ‒ No. 58(2). – pp. 55-76.
